- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on SGLT2-Inhibitors in France
Total 66 results
-
Groupe Hospitalier Pitie-SalpetriereVanderbilt University Medical CenterCompleted
-
Nantes University HospitalCompletedProton Pump Inhibitors | DeprescriptionFrance
-
Nantes University HospitalCompletedProton Pump Inhibitors | DeprescriptionFrance
-
Groupe Hospitalier Paris Saint JosephCompleted
-
Institut BergoniéInstitut National de la Santé Et de la Recherche Médicale, FranceCompletedCancer Treated With Immune-checkpoint InhibitorsFrance
-
Groupe Hospitalier Paris Saint JosephCompletedProton Pump InhibitorFrance
-
Centre Hospitalier Universitaire, AmiensCentral Hospital Saint QuentinRecruitingImmunotherapy | Immune Checkpoint Inhibitors | Immune-related Adverse Event | Predictive BiomarkersFrance
-
Institut Mutualiste MontsourisInstitut CurieRecruitingCancer | Immune Checkpoint Inhibitor | Cardiovascular BiomarkersFrance
-
Institut Mutualiste MontsourisRecruitingCancer | Cardiovascular Complication | Immune Checkpoint Inhibitor | Immune-related Adverse EventFrance
-
Fondation Ophtalmologique Adolphe de RothschildCompletedMEK Inhibitor-Associated Serous RetinopathyFrance
-
Institut CurieRecruitingQuality of Life | Cancer | IMMUNE CHECKPOINT INHIBITORFrance
-
Novo Nordisk A/SCompletedHealthy | Congenital Bleeding Disorder | Haemophilia A With Inhibitors | Haemophilia B With InhibitorsFrance
-
Assistance Publique - Hôpitaux de ParisRecruitingCancer | Immune Checkpoint Inhibitors | Metabolism DisorderFrance
-
University Hospital, BordeauxRecruitingStroke | Atrial Fibrillation | Anticoagulants | Platelet Aggregation Inhibitors | Atrial AppendageFrance
-
University Hospital, MontpellierCryoMed MillenaireRecruitingBreast Cancer | Aromatase InhibitorsFrance
-
Groupe Hospitalier Pitie-SalpetriereInstitut CurieCompletedCancer | Immune Checkpoint Inhibitor-Related Myocarditis | Immune-related Adverse EventFrance
-
Novo Nordisk A/SCompletedHealthy | Congenital Bleeding Disorder | Haemophilia A With Inhibitors | Haemophilia B With Inhibitors | Acquired Bleeding Disorder | Acquired Haemophilia | Congenital FVII Deficiency | Glanzmann's DiseaseFrance
-
University Hospital, BrestCompletedNon Small Cell Lung Cancer Metastatic | Prognosis | Thyroid Dysfunction | Immune Checkpoint Inhibitor | Treatment Adverse EffectFrance
-
Centre Hospitalier Universitaire, AmiensWithdrawnLung Cancer | Immune Checkpoint Inhibitor | Liver Biomarkers | TransaminasesFrance
-
Klinikum NürnbergRecruitingChronic Renal Failure | Mechanistic Effects of SGLT2 Inhibition and/ or MR Antagonism on Body Fluid and Electrolyte HomeostatisGermany, France
-
University Hospital, MontpellierTerminatedChronic Spotaneous Urticaria, Idiopathic Non Histaminergic Angioderma, Hereditary Angioedema With C1 Inhibitor DeficiencyFrance
-
Novo Nordisk A/SCompletedCongenital Bleeding Disorder | Haemophilia A With Inhibitors | Haemophilia B With InhibitorsUnited States, Denmark, France, United Kingdom
-
University Hospital, CaenCompletedDelirium | Hyponatremia | Proton Pump Inhibitor Adverse ReactionFrance
-
Pharvaris Netherlands B.V.RecruitingHereditary Angioedema | Hereditary Angioedema Type I | Hereditary Angioedema Type II | Hereditary Angioedema Types I and II | Hereditary Angioedema Attack | Hereditary Angioedema With C1 Esterase Inhibitor Deficiency | Hereditary Angioedema - Type 1 | Hereditary Angioedema - Type 2 | C1 Esterase Inhibitor... and other conditionsUnited States, Bulgaria, Czechia, Hungary, Spain, France, Germany, Poland, Canada, Israel
-
Hospices Civils de LyonNot yet recruitingImmune Checkpoint Inhibitors | Gestational Trophoblastic TumoursFrance
-
Blueprint Medicines CorporationActive, not recruitingNeoplasms | Neoplasms by Histologic Type | Lung Diseases | Neoplasms by Site | Adenocarcinoma | Carcinoma | Carcinoma, Non-Small-Cell Lung | Lung Neoplasms | Respiratory Tract Neoplasms | Thoracic Neoplasms | Carcinoma, Bronchogenic | Bronchial Neoplasms | Neoplasms, Nerve Tissue | EGF-R Positive Non-Small Cell Lung... and other conditionsUnited States, Canada, Taiwan, Korea, Republic of, Singapore, Japan, United Kingdom, France, Netherlands, Spain
-
MacroGenicsRecruitingProstate Cancer Recurrent | Immunotherapy | Androgen-Independent Prostatic Cancer | Androgen-Resistant Prostatic Cancer | Hormone Refractory Prostatic Cancer | Immune Checkpoint Inhibitor | Androgen-Independent Prostatic Neoplasms | Androgen-Insensitive Prostatic Cance | Inhibitory Checkpoint MoleculeUnited States, Spain, France, Belgium, United Kingdom, Poland, Georgia, Bulgaria, Puerto Rico, Australia
-
Novo Nordisk A/SCompletedCongenital Bleeding Disorder | Haemophilia A With Inhibitors | Haemophilia B With InhibitorsFrance, United Kingdom, Spain, Israel, Poland, Turkey, Hungary
-
Novo Nordisk A/SActive, not recruitingHaemophilia A Without Inhibitors | Haemophilia B Without InhibitorsSpain, United States, Korea, Republic of, United Kingdom, Australia, Lithuania, France, Turkey, India, Estonia, Russian Federation, Ukraine, Mexico, Japan, South Africa, Serbia, Canada, Croatia, Algeria, Bosnia and Herzegovina, ... and more
-
University Hospital, GrenobleUniversity Hospital, Rouen; University Hospital, ParisRecruitingAngio-Oedema Caused by Angiotensin-Converting-Enzyme InhibitorFrance
-
Institut CurieRecruitingNSCLC Patient in a Metastatic Stage Eligible for First-line Treatment With Immune Checkpoint InhibitorFrance
-
Novo Nordisk A/SActive, not recruitingHaemophilia A With Inhibitors | Haemophilia B With InhibitorsSpain, Korea, Republic of, India, Australia, United Kingdom, Russian Federation, Poland, Ukraine, Thailand, Mexico, United States, Turkey, Japan, South Africa, Serbia, France, Croatia, Denmark, Algeria, Bulgaria, Malaysia, Portugal, Slovaki... and more
-
Novo Nordisk A/SCompletedCongenital Bleeding Disorder | Haemophilia A With Inhibitors | Haemophilia B With InhibitorsFrance, United States, Sweden, Serbia, Turkey, United Kingdom, Malaysia, Brazil, Former Serbia and Montenegro, Japan, South Africa
-
Novo Nordisk A/SCompletedCongenital Bleeding Disorder | Haemophilia A With Inhibitors | Haemophilia B With InhibitorsSaudi Arabia, Algeria, Turkey, Germany, Poland, Netherlands, Italy, Belgium, South Africa, United Kingdom, Sweden, Austria, Portugal, France, Czech Republic, Venezuela
-
AstraZenecaHutchinson MediPharma (HMP)Active, not recruitingKidney Neoplasms | Carcinoma, Renal Cell | Urologic Neoplasms | Neoplasms by Site | Kidney Diseases | Carcinoma | Enzyme Inhibitors | Protein Kinase InhibitorsUnited States, Italy, France, Korea, Republic of, Brazil, Russian Federation, Ukraine
-
Novo Nordisk A/SCompletedCongenital Bleeding Disorder | Haemophilia A With Inhibitors | Haemophilia B With InhibitorsSlovakia, Spain, Argentina, Germany, Croatia, Italy, Canada, United Kingdom, Ireland, Sweden, France, United States, Czech Republic, Switzerland
-
Novo Nordisk A/SCompletedHaemophilia A With Inhibitors | Haemophilia B With Inhibitors | Haemophilia A | Haemophilia BFrance, United States, India, Mexico, United Kingdom, Netherlands, Sweden, Korea, Republic of, Spain, Switzerland, Serbia, Turkey, Bulgaria, Italy, Japan, Poland, South Africa, Croatia, Algeria, Australia, Bosnia and Herzegovina, ... and more
-
University Hospital, BordeauxNot yet recruitingAlzheimer Disease | Cholinesterase InhibitorsFrance
-
Centre Francois BaclesseNational Cancer Institute, FranceRecruitingRadiotherapy | PARP Inhibitor | Malignant GliomasFrance
-
French Innovative Leukemia OrganisationBristol-Myers SquibbCompletedSmall Lymphocytic Leukemia | CLL, Relapsed | CLL, Refractory | Bruton Tyrosine Kinase InhibitorFrance
-
Federation Francophone de Cancerologie DigestiveRecruitingMetastatic Colorectal Cancer | MSS | pMMR | Immune Checkpoint Inhibitor | Internal RadiotherapyFrance
-
Fondazione IRCCS Ca' Granda, Ospedale Maggiore...UnknownHemophilia A With InhibitorsUnited States, Germany, France, Italy, Romania, Spain
-
Insel Gruppe AG, University Hospital BernSahajanand Medical Technologies LimitedRecruitingAtrial Fibrillation (AF) | Oral Anticoagulation | Percutaneous Coronary Intervention (PCI) | P2Y12 InhibitorSpain, France, Switzerland, United Kingdom, Germany, Belgium, Italy, Netherlands, Poland
-
Central Hospital, Nancy, FranceCompletedAdenocarcinoma of Lung Stage IV | Adenocarcinoma of Lung, Response to Tyrosine Kinase Inhibitor in, SomaticFrance
-
Hoffmann-La RocheActive, not recruitingHemophilia A | Mild Hereditary Factor VIII Deficiency Disease Without Inhibitor | Moderate Hereditary Factor VIII Deficiency Disease Without InhibitorUnited States, Netherlands, Belgium, France, Germany, South Africa, Spain, Canada, United Kingdom, Poland
-
Poitiers University HospitalRecruitingChronic Myeloid Leukemia | Tyrosine Kinase InhibitorsFrance
-
University Hospital, CaenCompletedChronic Myeloid Leukemia | Withdrawal Syndrome | Tyrosine Kinase InhibitorFrance
-
Novo Nordisk A/SCompletedCongenital Bleeding Disorder | Haemophilia A With Inhibitors | Haemophilia B With InhibitorsFrance, United States, Spain, Brazil, Philippines, South Africa, Poland, Turkey, Romania, Bulgaria, Russian Federation, Argentina
-
Pharvaris Netherlands B.V.CompletedHereditary Angioedema | Hereditary Angioedema Type I | Hereditary Angioedema Type II | Hereditary Angioedema Types I and II | Hereditary Angioedema Attack | Hereditary Angioedema With C1 Esterase Inhibitor Deficiency | Hereditary Angioedema - Type 1 | Hereditary Angioedema - Type 2 | C1 Esterase Inhibitor... and other conditionsBulgaria, United States, Spain, Israel, Germany, Canada, Czechia, France, Hungary, Italy, Netherlands, Poland, United Kingdom
-
Novo Nordisk A/SCompletedCongenital Bleeding Disorder | Haemophilia A With Inhibitors | Haemophilia B With InhibitorsTaiwan, United Kingdom, Thailand, Serbia, Croatia, Italy, Poland, Romania, Hungary, Malaysia, United States, Austria, Brazil, Greece, Japan, Puerto Rico, Russian Federation, South Africa, Turkey